FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Front Vet Sci / Expression of matrix metalloproteinases (MMPs)-2/-7/-9/-14 a...
Frontiers in veterinary science2022; 9; 1063580; doi: 10.3389/fvets.2022.1063580

Expression of matrix metalloproteinases (MMPs)-2/-7/-9/-14 and tissue inhibitors of MMPs (TIMPs)-1/-2 in bovine cutaneous fibropapillomas associated with BPV-2 infection.

Abstract: Bovine papillomaviruses -1/-2 (BPVs) are small non-enveloped double-stranded DNA viruses able to infect the skin of bovids and equids, causing development of neoplastic lesions such as bovine cutaneous fibropapillomas and equine sarcoid. Matrix metalloproteinases (MMPs) are a group of zinc-dependent endopeptidases that degrade basal membrane and extracellular matrix, whose function is essential in physiological processes such as tissue remodeling and wound healing. MMPs activity is finely regulated by a balancing with expression of tissue inhibitors of MMPs (TIMPs), a process that is impaired during tumour development. BPV infection is associated with upregulation of MMPs and /or their unbalancing with TIMPs, contributing to local invasion and impairment of extracellular matrix remodeling in equine sarcoid; however, studies regarding this topic in bovine fibropapillomas are lacking. Unassigned: The aim of this study was to perform an immunohistochemical and biochemical analysis on a panel of MMPs and TIMPs in BPV-2 positive bovine cutaneous fibropapillomas vs. normal skin samples. Unassigned: Immunohistochemistry revealed a cytoplasmic expression of MMP-2 (15/19), a cytoplasmic and perinuclear immunoreactivity of MMP-7 (19/19) and MMP-9 (19/19), along with a cytoplasmic and nuclear pattern of MMP-14 (16/19), accompanied by a cytoplasmic expression of TIMP-1 (14/19) and TIMP-2 (18/19) in tumour samples; western blotting revealed an overexpression of MMP-2 (8/9), MMP-7 (9/9) and MMP-9 (9/9), and a decreased level of MMP-14 (9/9), TIMP-1 (9/9) and TIMP-2 (9/9) in tumour versus normal skin samples. Moreover, gelatine zymography confirmed the expression of pro-active MMP-2 (9/9) and MMP-9 (9/9) and, most importantly, indicated the presence and increased activity of their active forms (82 and 62 kDa, respectively) in tumour samples. Unassigned: This is the first study describing MMPs and TIMPs in bovine cutaneous fibropapillomas and our results suggest that their unbalanced expression in presence of BPV-2 may play a significant role in tumour development. A further analysis of supplementary MMPs and TIMPs could bring new important insights into the papillomavirus induced tumours.
Copyright © 2022 Daraban Bocaneti, Altamura, Corteggio, Tanase, Dascalu, Pasca, Hritcu, Mares and Borzacchiello.
Get Full Text
Publication Date: 2022-11-28 PubMed ID: 36518899PubMed Central: PMC9744227DOI: 10.3389/fvets.2022.1063580Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research focuses on the occurrence and interplay of certain proteins called matrix metalloproteinases and their inhibitors in growths on cow skin connected to two strains of bovine papillomavirus. The study suggests that an imbalance in these protein levels could be a key factor in the development of these tumors.

Background

  • The two strains of bovine papillomavirus (BPVs), BPV-1 and BPV-2, are known to infect the skin of bovids and equids, leading to growths or tumors.
  • Matrix metalloproteinases (MMPs) are proteins that help with tissue remodeling and wound healing by breaking down the structures that make up our tissues.
  • The activity of these MMPs is regulated by other proteins called tissue inhibitors of MMPs (TIMPs), and imbalances in the levels of these proteins can lead to disease development.
  • Prior research has suggested that a BPV infection can disrupt the balance of these proteins, but the specifics of this in the context of bovine skin tumors has not been studied in depth before.

Methodology

  • The primary goal of this study was to identify and analyse the expressions of specific MMPs and TIMPs in skin samples with BPV-2 positive bovine cutaneous fibropapillomas (skin tumors).
  • They used a technique known as immunohistochemistry (a method to visually detect the presence of specific proteins in a tissue) on the samples collected.
  • They also used western blotting, a method for detecting specific proteins, and gelatine zymography, a technique used to detect and quantify enzymatic activity of MMPs.

Findings and Interpretations

  • Immunohistochemistry revealed evidence of several MMPs and TIMPs present in the skin tumor samples.
  • Additionally, the use of western blotting revealed higher levels of MMP-2, MMP-7 and MMP-9 and lower levels of MMP-14, TIMP-1 and TIMP-2 in the tumor samples compared to normal skin samples.
  • Gelatine zymography confirmed the presence and increased activity of MMP-2 and MMP-9 in the tumor samples. This implies that the presence and imbalance of MMPs and TIMPs in the presence of BPV-2 play a significant role in the development of the skin tumors in bovines.

Implications and Future Research

  • This being the first study to describe the occurrences of MMPs and TIMPs in bovine cutaneous fibropapillomas, it adds significant knowledge to the understanding of the molecular mechanisms underlying the tumor development in these BPV-2 infections.
  • If further analysis of additional MMPs and TIMPs could be carried out, this could lead to even deeper insights into this kind of tumor development induced by papillomavirus.

Cite This Article

APA
Daraban Bocaneti F, Altamura G, Corteggio A, Tanase OI, Dascalu MA, Pasca SA, Hritcu O, Mares M, Borzacchiello G. (2022). Expression of matrix metalloproteinases (MMPs)-2/-7/-9/-14 and tissue inhibitors of MMPs (TIMPs)-1/-2 in bovine cutaneous fibropapillomas associated with BPV-2 infection. Front Vet Sci, 9, 1063580. https://doi.org/10.3389/fvets.2022.1063580

Publication

Frontiers in veterinary science
ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 9
Pages: 1063580

Researcher Affiliations

Daraban Bocaneti, Florentina
  • Department of Public Health, Faculty of Veterinary Medicine, Iasi University of Life Sciences "Ion Ionescu de la Brad", Iaşi, Romania.
Altamura, Gennaro
  • Department of Veterinary Medicine and Animal Productions, University of Naples "Federico II", Naples, Italy.
Corteggio, Annunziata
  • Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Naples, Italy.
Tanase, Oana Irina
  • Department of Public Health, Faculty of Veterinary Medicine, Iasi University of Life Sciences "Ion Ionescu de la Brad", Iaşi, Romania.
Dascalu, Mihaela Anca
  • Department of Public Health, Faculty of Veterinary Medicine, Iasi University of Life Sciences "Ion Ionescu de la Brad", Iaşi, Romania.
Pasca, Sorin Aurelian
  • Department of Pathology, Faculty of Veterinary Medicine, Iasi University of Life Sciences "Ion Ionescu de la Brad", Iaşi, Romania.
Hritcu, Ozana
  • Department of Veterinary Medicine and Animal Productions, University of Naples "Federico II", Naples, Italy.
Mares, Mihai
  • Department of Public Health, Faculty of Veterinary Medicine, Iasi University of Life Sciences "Ion Ionescu de la Brad", Iaşi, Romania.
Borzacchiello, Giuseppe
  • Department of Veterinary Medicine and Animal Productions, University of Naples "Federico II", Naples, Italy.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 49 references
  1. Bocaneti F, Altamura G, Corteggio A, Velescu E, Roperto F, Borzacchiello G. Bovine papillomavirus: new insights into an old disease.. Transbound Emerg Dis (2016) 63:14–23.
    doi: 10.1111/tbed.12222pubmed: 24661978google scholar: lookup
  2. Nasir L, Brandt S. Papillomavirus associated diseases of the horse.. Vet Microbiol (2013) 167:159–67.
    doi: 10.1016/j.vetmic.2013.08.003pubmed: 24016387google scholar: lookup
  3. Knottenbelt DC. A suggested clinical classification for the equine sarcoid.. Clin Tech Equine Pract (2005) 4:278–95.
    doi: 10.1053/j.ctep.2005.10.008pubmed: 0google scholar: lookup
  4. Zwandor NJ, Akalusi Y, Ngulukun SS, Meseko CA, Akanbi BO, Adedeji JA. Severe cutaneous bovine papillomatosis in a cattle herd.. Vom J Vet Sci (2008) 5:1–6.
  5. Wernert N. The multiple roles of tumour stroma.. Virchows Archiv (1997) 430:433–43.
    doi: 10.1007/s004280050053pubmed: 9230908google scholar: lookup
  6. Johnsen M, Lund LR, Rømer J, Almholt K, Danø K. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation.. Curr Opin Cell Biol (1998) 10:667–71.
    doi: 10.1016/S0955-0674(98)80044-6pubmed: 9818179google scholar: lookup
  7. Kähäri VM, Saarialho-Kere U. Matrix metalloproteinases in skin.. Exp Dermatol (1997) 6:199–213.
    doi: 10.1111/j.1600-0625.1997.tb00164.xpubmed: 9450622google scholar: lookup
  8. Westermarck J, Kähäri V. Regulation of matrix metalloproteinase expression in tumor invasion.. FASEB J (1999) 13:781–92.
    doi: 10.1096/fasebj.13.8.781pubmed: 10224222google scholar: lookup
  9. Akgül B, Pfefferle R, Marcuzzi GP, Zigrino P, Krieg T, Pfister H. Expression of matrix metalloproteinase (MMP)-2, MMP-9, MMP-13, and MT1-MMP in skin tumors of human papillomavirus type 8 transgenic mice.. Exp Dermatol (2006) 15:35–42.
    doi: 10.1111/j.0906-6705.2005.00387.xpubmed: 16364029google scholar: lookup
  10. Bassiouni W, Ali MAM, Schulz R. Multifunctional intracellular matrix metalloproteinases: implications in disease.. FEBS Journal (2021) 288:7162–82.
    doi: 10.1111/febs.15701pubmed: 33405316google scholar: lookup
  11. Curran S, Murray GI. Matrix metalloproteinasesmolecular aspects of their roles in tumour invasion and metastasis.. Eur J Cancer (2000) 36:1621–30.
    doi: 10.1016/S0959-8049(00)00156-8pubmed: 10959048google scholar: lookup
  12. Vihinen P, Kähäri VM. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.. Int J Cancer (2002) 99:157–66.
    doi: 10.1002/ijc.10329pubmed: 11979428google scholar: lookup
  13. Hauff SJ, Raju SC, Orosco RK, Gross AM, Diaz-Perez JA, Savariar E. Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice.. Otolaryngol Head Neck Surg (2014) 151:612–8.
    doi: 10.1177/0194599814545083pmc: PMC4469264pubmed: 25091190google scholar: lookup
  14. Mosseri S, Hetzel U, Hahn S, Michaloupoulou E, Sallabank HC, Knottenbelt DC. Equine sarcoid: in situ demonstration of matrix metalloproteinase expression.. Vet J (2014) 202:279–85.
    doi: 10.1016/j.tvjl.2014.07.026pmc: PMC7128672pubmed: 25439440google scholar: lookup
  15. Martano M, Corteggio A, Restucci B, De Biase ME, Borzacchiello G, Maiolino P. Extracellular matrix remodeling in equine sarcoid: an immunohistochemical and molecular study.. BMC Vet Res (2016) 12:1–10.
    doi: 10.1186/s12917-016-0648-1pmc: PMC4736642pubmed: 26838095google scholar: lookup
  16. Katori H, Nozawa A, Tsukuda M. Increased expression of matrix metalloproteinase-2 and 9 and human papilloma virus infection are associated with malignant transformation of sinonasal inverted papilloma.. J Surg Oncol (2006) 93:80–5.
    doi: 10.1002/jso.20386pubmed: 16353190google scholar: lookup
  17. Karelina TV, Goldberg GI, Eisen AZ. Matrilysin (PUMP) correlates with dermal invasion during appendageal development and cutaneous neoplasia.. J Invest Dermatol (1994) 103:482–7.
    doi: 10.1111/1523-1747.ep12395596pubmed: 7930671google scholar: lookup
  18. Kerkelä E, Saarialho-Kere U. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer.. Exp Dermatol (2003) 12:109–25.
    doi: 10.1034/j.1600-0625.2003.120201.xpubmed: 12702139google scholar: lookup
  19. Gálvez BG, Matías-Román S, Albar JP, Sánchez-Madrid F, Arroyo AG. Membrane Type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling.. J Biol Chem (2001) 276:37491–500.
    doi: 10.1074/jbc.M104094200pubmed: 11448964google scholar: lookup
  20. Podstawski P, Ropka-Molik K, Semik-Gurgul E, Samiec M, Skrzyszowska M, Podstawski Z. Assessment of BPV-1 mediated matrix metalloproteinase genes deregulation in the in vivo and in vitro models designed to explore molecular nature of equine sarcoids.. Cells (2022) 11:1268.
    doi: 10.3390/cells11081268pmc: PMC9025493pubmed: 35455948google scholar: lookup
  21. Murphy G. Tissue inhibitors of metalloproteinases.. Genome Biol (2011) 12:233.
    doi: 10.1186/gb-2011-12-11-233pmc: PMC3334591pubmed: 22078297google scholar: lookup
  22. Silva MA, Altamura G, Corteggio A, Roperto F, Bocaneti F, Velescu E. Expression of connexin 26 and bovine papillomavirus E5 in cutaneous fibropapillomas of cattle.. Vet J (2013) 195:337–43.
    doi: 10.1016/j.tvjl.2012.07.009pubmed: 22892185google scholar: lookup
  23. Bocaneti F, Altamura G, Corteggio A, Velescu E, Borzacchiello G. Expression of bcl-2 and p53 in bovine cutaneous fibropapillomas.. Infect Agent Cancer (2015) 10:2.
    doi: 10.1186/1750-9378-10-2pmc: PMC4298047pubmed: 25601891google scholar: lookup
  24. Bocaneti F, Altamura G, Corteggio A, Solcan C, Velescu E, Borzacchiello G. Expression of cyclooxygenase-2 in naturally occurring bovine cutaneous fibropapillomas.. Pol J Vet Sci (2015) 18:455–8.
    doi: 10.1515/pjvs-2015-0084pubmed: 26618600google scholar: lookup
  25. Bocaneti F, Altamura G, Corteggio A, Martano M, Roperto F, Velescu E. Expression of platelet derived growth factor β receptor, its activation and downstream signals in bovine cutaneous fibropapillomas.. Res Vet Sci (2013) 94:596–601.
    doi: 10.1016/j.rvsc.2012.10.011pubmed: 23122810google scholar: lookup
  26. Bocaneti Daraban F, Dascalu MA, Tanase OI, Pasca SA MM. Bovine papillomavirus type 2 is harbourded in cattle cutaneous warts.. Sci Pap Vet Med Iasi Univ Life Sci (2021) 64:18–21.
  27. Goldschmidt MH, Goldschmidt KH. Epithelial and melanocytic tumors of the skin.. In:Meuten DJ, editors. Tumors in Domestic Animals. Hoboken, NJ: John Wiley & Sons, Inc. (2016), p. 88–141.
  28. Aresu L, Giantin M, Morello E, Vascellari M, Castagnaro M, Lopparelli R. Matrix metalloproteinases and their inhibitors in canine mammary tumors.. BMC Vet Res (2011) 7:33.
    doi: 10.1186/1746-6148-7-33pmc: PMC3141405pubmed: 21726449google scholar: lookup
  29. Altamura G, Power K, Martano M, degli Uberti B, Galiero G, De Luca G. Felis catus papillomavirus type-2 E6 binds to E6AP, promotes E6AP/p53 binding and enhances p53 proteasomal degradation.. Sci Rep (2018) 8:17529.
    doi: 10.1038/s41598-018-35723-7pmc: PMC6277439pubmed: 30510267google scholar: lookup
  30. Gil da. Costa RM, Peleteiro MC, Pires MA, DiMaio D. An update on canine, feline and bovine papillomaviruses.. Transbound Emerg Dis (2017) 64:1371–9.
    doi: 10.1111/tbed.12555pubmed: 27615361google scholar: lookup
  31. Borzacchiello G, Roperto F. Bovine papillomaviruses, papillomas and cancer in cattle.. Vet Res (2008) 39:45.
    doi: 10.1051/vetres:2008022pubmed: 18479666google scholar: lookup
  32. Toriseva M, Laato M, Carpén O, Ruohonen ST, Savontaus E, Inada M. MMP-13 regulates growth of wound granulation tissue and modulates gene expression signatures involved in inflammation, proteolysis, and cell viability.. PLoS ONE (2012) 7:e42596.
    doi: 10.1371/journal.pone.0042596pmc: PMC3413640pubmed: 22880047google scholar: lookup
  33. Yuan ZQ, Gobeil PAM, Campo MS, Nasir L. Equine sarcoid fibroblasts over-express matrix metalloproteinases and are invasive.. Virology (2010) 396:143–51.
    doi: 10.1016/j.virol.2009.10.010pubmed: 19896685google scholar: lookup
  34. Kawamata H, Uchida D, Hamano H, Kimura-Yanagawa T, Nakashiro KI, Hino S. Active-MMP2 in cancer cell nests of oral cancer patients: correlation with lymph node metastasis.. Int J Oncol (1998) 13:699–704.
    doi: 10.3892/ijo.13.4.699pubmed: 9735398google scholar: lookup
  35. Yabluchanskiy A, Ma Y, Iyer RP, Hall ME, Lindsey ML. Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.. Physiology (2013) 28:391–403.
    doi: 10.1152/physiol.00029.2013pmc: PMC3858212pubmed: 24186934google scholar: lookup
  36. Karakurt E, Aydin U, Beytut E, Dag S, Ermutlu CS, Aksoy Ö. Prognostic significance of PCNA, MMP-9 and p53 in bovine ocular squamous cell carcinomas.. J Res Vet Med (2021) 40:98–105.
    doi: 10.30782/jrvm.937240google scholar: lookup
  37. Altamura G, Martano M, Licenziato L, Maiolino P, Borzacchiello G. Telomerase reverse transcriptase (TERT) expression, telomerase activity, and expression of matrix metalloproteinases (MMP)-1/-2/-9 in feline oral squamous cell carcinoma cell lines associated with Felis catus papillomavirus type-2 infection.. Front Vet Sci (2020) 7:148.
    doi: 10.3389/fvets.2020.00148pmc: PMC7118734pubmed: 32292795google scholar: lookup
  38. Thomas GT, Lewis MP, Speight PM. Matrix metalloproteinases and oral cancer.. Oral Oncol (1999) 35:227–33.
    doi: 10.1016/S1368-8375(99)00004-4pubmed: 10621841google scholar: lookup
  39. Kaewprag J, Umnajvijit W, Ngamkham J, Ponglikitmongkol M. HPV16 oncoproteins promote cervical cancer invasiveness by upregulating specific matrix metalloproteinases.. PLoS ONE (2013) 8:e71611.
    doi: 10.1371/journal.pone.0071611pmc: PMC3742460pubmed: 23967226google scholar: lookup
  40. Sabeh F, Ota I, Holmbeck K, Birkedal-Hansen H, Soloway P, Balbin M. Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP.. J Cell Biol (2004) 167:769–81.
    doi: 10.1083/jcb.200408028pmc: PMC2172570pubmed: 15557125google scholar: lookup
  41. De Vicente JC, Lequerica-Fernández P, Santamaría J, Fresno MF. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.. J Oral Pathol Med (2007) 36:415–24.
    doi: 10.1111/j.1600-0714.2007.00546.xpubmed: 17617835google scholar: lookup
  42. Zhu L, Zheng X, Du Y, Xing Y, Xu K, Cui L. Matrix metalloproteinase-7 may serve as a novel biomarker for cervical cancer.. Onco Targets Ther (2018) 11:4207–20.
    doi: 10.2147/OTT.S160998pmc: PMC6055895pubmed: 30050312google scholar: lookup
  43. Leighl NB, Paz-Ares L, Douillard JY, Peschel C, Arnold A, Depierre A. Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: national cancer institute of canada-clinical trials group study BR.18.. J Clin Oncol (2005) 23:2831–9.
    doi: 10.1200/JCO.2005.04.044pubmed: 15837997google scholar: lookup
  44. De Vicente JC, Fresno MF, Villalain L, Vega JA, Arranz JSL. Immunoexpression and prognostic significance of TIMP-1 and−2 in oral squamous cell carcinoma.. Oral Oncol (2005) 41:568–79.
    doi: 10.1016/j.oraloncology.2004.12.008pubmed: 15925538google scholar: lookup
  45. Ma J, Wang J, Fan W, Pu X, Zhang D, Fan C. Upregulated TIMP-1 correlates with poor prognosis of laryngeal squamous cell carcinoma.. Int J Clin Exp Pathol (2014) 7:246–54.
    pmc: PMC3885479pubmed: 24427345
  46. Carpén T, Sorsa T, Jouhi L, Tervahartiala T, Haglund C, Syrjänen S. High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer.. Cancer Immunol Immunother (2019) 68:1263–72.
    doi: 10.1007/s00262-019-02362-4pmc: PMC6682571pubmed: 31240326google scholar: lookup
  47. Sakata K, Shigemasa K, Nagai N, Ohama K. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.. Int J Oncol (2000) 17:673–81.
    doi: 10.3892/ijo.17.4.673pubmed: 10995877google scholar: lookup
  48. Branca M, Ciotti M, Giorgi C, Santini D, Di Bonito L, Costa S. Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN.. Anticancer Res (2006) 26:1543–56.
    pubmed: 16619570
  49. Sheu BC, Lien HC, Ho HN, Lin HH, Chow SN, Huang SC. Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer.. Cancer Res (2003) 63:6537–42.
    pubmed: 14559848
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.